概要
Deciphex builds two digital pathology platforms: Diagnexia, which connects subspecialty pathologists for rapid diagnostics and backlog reduction, and Patholytix, which accelerates drug development through preclinical safety assessment. Based at Dublin City University's Alpha campus, it manages a network of more than 250 subspecialty pathologists and processes roughly 97,000 cases a year. The venture debt funds US expansion. Headquartered in Dublin.
資金調達
| ラウンド |
金額 |
発表日 |
投資家 |
|
Debt
|
会員限定 |
会員限定 |
投資家 1社 |